Ticker Scorecard - MGNX Basics Company: MacroGenics, Inc. IPO Date: October 10, 2013 Sector: Healthcare Industry: Biotech Market Cap: $173.23M Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.01% Avg Daily Range (30 D): $0.08 | 2.71% Avg Daily Range (90 D): $0.11 | 3.13% Institutional Daily Volume Avg Daily Volume: .54M Avg Daily Volume (30 D): .63M Avg Daily Volume (90 D): .54M Trade Size Avg Trade Size (Sh.): 105 Avg Trade Size (Sh.) (30 D): 130 Avg Trade Size (Sh.) (90 D): 109 Institutional Trades Total Inst.Trades: 2,250 Avg Inst. Trade: $1.68M Avg Inst. Trade (30 D): $1M Avg Inst. Trade (90 D): $.72M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.73M Avg Closing Trade (30 D): $1M Avg Closing Trade (90 D): $.72M Avg Closing Volume: 107.5K     News Feb 6, 2025 @ 7:40 PM Investigation Alert: MacroGenics, Apellis Pharmace... Source: Johnson Fistel, Llp Jan 9, 2025 @ 9:52 AM Immunotoxins Market Trends and Regional Business O... Source: Researchandmarkets.Com Oct 23, 2024 @ 9:39 PM Investigation Alert: MacroGenics, Apellis Pharmace... Source: Johnson Fistel, Llp Oct 7, 2024 @ 5:00 PM Innovative B7-H3 Inhibitors Set to Transform Cance... Source: Delveinsight Sep 24, 2024 @ 10:49 AM Hagens Berman Alerts MacroGenics (MGNX) Investors ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.57 $.9 $-.89 Diluted EPS $-1.57 $.9 $-.89 Revenue $ 141.33M $ 110.71M $ 10.8M Gross Profit $ 140.55M $ 110.54M $ 10.62M Net Income / Loss $ -97.62M $ 56.31M $ -55.66M Operating Income / Loss $ -107.09M $ 54.19M $ -58.18M Cost of Revenue $ .78M $ .17M $ .18M Net Cash Flow $ 89.73M $ 95.69M $ 3.58M PE Ratio